Stanford researchers watch in real time bacteria building their protective outer shell. Their findings may help develop treatments for bacterial pathogens.
Two color-changing compounds found in scorpion venom can help kill the bacteria responsible for staphylococcus and drug-resistant tuberculosis.
The U.S. Preventive Services Task Force now recommends HIV screening for those aged 15-65 and increased use of PrEP, a pill that helps prevent infection.
The parasite that causes malaria is remarkably adept at developing resistance to the drugs devised to combat it. But new research suggests a solution.
In this Q&A, Stanford physician-scientists Stanley Deresinski and Marisa Holubar explain why responsible use of antibiotics is so important worldwide.
Third-year medical student Neil Rens explains why he chooses to advocate for stricter vaccination requirements in California.
Stanford researchers are using lab-grown heart cells to investigate how Chagas disease, which is spread by "kissing bugs," affects heart health.
Helicobacter pylori, a potentially nasty bacteria, somehow lives in one of every two human stomachs -- no mean feat. Here's how the bug pulls it off.
Stanford researchers have developed a technique to encourage the immune system to target a section of the flu virus that is conserved year to year.
Scientists at Stanford and beyond are working toward a new type of tuberculosis diagnostic that utilizes blood samples.
P. aeruginosa, a type of bacteria, is increasingly drug-resistant, and there's no vaccine against it. But it has a recently discovered Achilles heel.
Infectious disease expert Desiree LaBeaud is mapping outbreaks of Zika, dengue and chikungunya, three viral diseases transmitted by the same mosquitoes.
For babies in developing countries, pneumonia vaccines seem to work better if their mothers receive treatment for parasitic infections during pregnancy.
Writer Amy Adams reflects on her own experience with measles, and her lingering fears that she may have spread the virus to someone who was vulnerable.
A Stanford study shows Hsp70 protein inhibitors can protect mice from Zika virus without developing drug resistance, demonstrating their clinical potential.
Stanford scientists have devised a way to predict the severity of dengue cases using a set of 20 genes and specific expression patterns.